Compare HRZN & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HRZN | QSI |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.7M | 273.7M |
| IPO Year | 2010 | N/A |
| Metric | HRZN | QSI |
|---|---|---|
| Price | $6.49 | $1.22 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $7.44 | $2.88 |
| AVG Volume (30 Days) | 565.4K | ★ 4.5M |
| Earning Date | 10-28-2025 | 11-05-2025 |
| Dividend Yield | ★ 19.94% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $98,899,000.00 | $3,177,000.00 |
| Revenue This Year | $3.03 | N/A |
| Revenue Next Year | $10.24 | $159.68 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 40.20 |
| 52 Week Low | $5.71 | $0.95 |
| 52 Week High | $9.99 | $5.77 |
| Indicator | HRZN | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 43.51 | 34.92 |
| Support Level | $6.37 | $1.26 |
| Resistance Level | $6.71 | $1.54 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 29.27 | 8.33 |
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.